World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02599428
Date of registration: 04/11/2015
Prospective Registration: Yes
Primary sponsor: Zealand University Hospital
Public title: Recovery After ICU Treatment: A Prospective Cohort Study
Scientific title: Recovery After ICU Treatment: A Prospective Cohort Study
Date of first enrolment: February 2016
Target sample size: 161
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02599428
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
Denmark
Contacts
Name:     Ole Mathiesen, MD
Address: 
Telephone:
Email:
Affiliation:  Zealand University Hospital, Køge Hospital
Key inclusion & exclusion criteria

Inclusion Criteria:

- Patients > 18 years of age

- Admitted to the ICU for > 24 h

Exclusion Criteria:

- Not able to speak and understand Danish

- Discharged from the ICU to terminal care

- Patients transferred to another hospital during ICU stay

- Patients living outside the Region of Zealand

- Patient with severe dementia



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Quality of Life
Critical Illness
Delirium
Intervention(s)
Primary Outcome(s)
Cognitive function measured by Repeatable Battery for the Assessments of Neuropsychological Status (RBANS) [Time Frame: 3 months after discharge]
Secondary Outcome(s)
Consumption of opioids at admission and on follow up [Time Frame: At admission to hospital, at 3 month follow up]
Mortality [Time Frame: At discharge from hospital (variable time) and at 90 days postdischarge]
Receiving statins before and after ICU stay [Time Frame: At admission to hospital, at 3 month follow up]
Consumption of anti-depressants before and after ICU stay [Time Frame: At admission to hospital, at 3 month follow up]
Cognitive function measured by Repeatable Battery for the Assessments of Neuropsychological Status (RBANS) [Time Frame: 12 months after discharge]
Adherence to checklist based on rehabilitation guidelines [Time Frame: At discharge from hospital and 3 months]
Anxiety and depression measured by Hospital anxiety and depression scale (HADS) [Time Frame: 3 and 12 months]
Physical function measured by Chelsea critical care physical assessment tool (CPAx) [Time Frame: 3 and 12 months]
Delirium at the ICU measured by CAM-ICU [Time Frame: At discharge from ICU (variable time)]
Health related quality of life measured by Short form health survey (SF 36) [Time Frame: 3 and 12 months]
Secondary ID(s)
SE 1-16
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history